Commonwealth Equity Services, LLC T2 Biosystems, Inc. Transaction History

Commonwealth Equity Services, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.09 - $565.0 $4,500 - $28.3 Million	50,000 Added 41.84%	169,510 $19,000
Q1 2022 May 04, 2022	BUY	$0.36 - $0.57 $10,800 - $17,100	30,000 Added 33.52%	119,510 $62,000
Q4 2021 Jan 31, 2022	BUY	$0.46 - $0.94 $12,880 - $26,320	28,000 Added 45.52%	89,510 $46,000
Q2 2021 Aug 11, 2021	BUY	$1.04 - $1.69 $2,340 - $3,802	2,250 Added 3.8%	61,510 $73,000
Q1 2021 May 04, 2021	BUY	$1.32 - $3.79 $1,887 - $5,419	1,430 Added 2.47%	59,260 $96,000
Q4 2020 Feb 11, 2021	BUY	$1.06 - $1.51 $1,223 - $1,742	1,154 Added 2.04%	57,830 $71,000
Q3 2020 Nov 05, 2020	BUY	$1.15 - $2.1 $16,468 - $30,072	14,320 Added 33.81%	56,676 $77,000
Q1 2020 May 11, 2020	BUY	$0.28 - $1.23 $8,680 - $38,130	31,000 Added 272.98%	42,356 $27,000
Q4 2019 Feb 05, 2020	SELL	$0.96 - $2.94 $1,728 - $5,292	-1,800 Reduced 13.68%	11,356 $13,000
Q3 2019 Oct 30, 2019	BUY	$0.58 - $3.01 $7,630 - $39,599	13,156 New	13,156 $32,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $5.99M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.